SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2013

SHAREHOLDERS' EQUITY [Abstract]

Schedule of Share Capital

The Company's share capital consisted of the following as of December 31, 2013 and 2012:

	Authorized December 31,				Issued and outstanding December 31,
	2013		2012		2013		2012
Shares of NIS 0.04 par value:
Ordinary shares		200,000,000		200,000,000		34,739,315		34,365,250

Summary of Stock Option Activity

The following is a summary of activities relating to the Company's stock options granted to employees among the Company's plan during the year ended December 31, 2013:

	Number  of options		Weighted average exercise price		Aggregate intrinsic value
Outstanding - beginning of  the year		1,545,200	$	11.13	$	7,516,949
Granted		-	$	-	$	-
Exercised		614,709	$	11.08	$	11,849,082
Forfeited		34,939	$	11.00	$	1,014,978
Outstanding - end of the year		895,552	$	10.58	$	35,005,220
Options exercisable at the end of the year		57,967	$	10.42	$	2,275,205
Vested and expected to vest		895,552	$	10.58	$	35,005,220

Schedule of Options Outstanding

The options outstanding as of December 31, 2013, have been separated into ranges of exercise price, as follows:

	Options outstanding						Options exercisable
Exercise price	Number of options		Weighted average remaining contractual life (years)		Weighted average exercise price per share		Number of options		Weighted average remaining contractual life (years)		Weighted average exercise price
$      10.42		865,552		5.22	$	10.42		57,967		5.22		10.42
$      15.26		30,000		5.85	$	15.26		-		-		-
		895,552						-		-		-

Schedule of Compensation Expenses

Compensation expenses related to options granted were recorded in the consolidated statements of operations, as follows:

	Year ended December 31,		Year ended December 31,
	2013		2012
Cost of revenues	$	149	$	185
Research and development expenses		35		106
Selling and marketing expenses		384		469
General and administrative expenses		1,946		2,900
Total	$	2,514	$	3,660